Physician peer influence affects repeat prescriptions: INFORMS Marketing Science

Peer influence among physicians affects repeat use of new prescription drug, INFORMS marketing science study finds

2015-07-14

(Press-News.org) A new study published in Marketing Science, a journal of the Institute for Operations Research and the Management Sciences (INFORMS), finds that peer influence among physicians can affect both trial and repeat prescription behavior of a risky new prescription drug. The study, Social Contagion in New Product Trial and Repeat, tracks prescriptions of a new drug over 17 months, and measures the discussion and patient referral connections among physicians in New York, Los Angeles, and San Francisco. The research was conducted by professors Raghuram Iyengar and Christophe Van den Bulte of the Wharton School, University of Pennsylvania, Philadelphia and Jae Young Lee of School of Business, Yonsei University, Seoul, Korea. Conventional thinking suggests that repeat prescriptions are primarily dependent on users' experience. The authors observe that repeat prescriptions are apparently affected by physicians' peers. They suggest that peer influence is not only informational but can also be "normative." Informational peer influence exists when people observe the behavior of their peers to learn about the new product's effectiveness or ease of use. Normative peer influence exists when people conform to others' expectations about accepted behavior. "Whereas informational influence is likely to decrease or even vanish as people proceed from first-time to repeat use, normative influence need not decline at all and may even increase," says Raghuram Iyengar. Those who are most influential differ between first-time and repeat use. Physicians, who are central in the social network and prescribe heavily, influence others in first-time use but not their repeat use. On the other hand, nearby colleagues influence repeat prescriptions. Physicians who do not consider themselves opinion leaders are most easily influenced about first-time use. For repeat use, in contrast, it is physicians in the middle of the status distribution, measured by how others turn to them to discuss treatment options or refer patients to them. Those at the very top and the very bottom of the status hierarchy don't appear to care what their colleagues do. "For public health officials and pharmaceutical managers, the findings suggest that campaigns to leverage peer influence should be designed and targeted differently, depending on whether they want to increase first-time use or repeat use," says Christophe Van den Bulte. Jae Young Lee adds, "Managers should target centrally located physicians for first time use and co-located physicians for repeat use. Managers should emphasize reducing perceived risk for first-time use and conforming to local norms for repeat use."

INFORMATION:

About ISMS The authors of the study are members of the INFORMS Society for Marketing Science, a group of scholars focused on describing, explaining, and predicting market phenomena at the interface of firms and consumers. This press release was prepared by the authors with the assistance of Gerard J. Tellis, ISMS VP of External Affairs. About INFORMS INFORMS is the leading international association for professionals in analytics and operations research (O.R.). INFORMS advances research, and develops and promotes best practices in analytics and O.R. through collaboration, knowledge sharing, and professional development. INFORMS helps business, government, and other organization professionals make better decisions to drive value to their organizations and society. Our certification program (CAP®), highly cited publications, educational meetings and conferences, continuing education, industry and process focused networking communities, competitions, and recognition provide professionals with the knowledge and connections they need to achieve ever greater value for their organizations. Further information about INFORMS, analytics, and operations research is at http://www.informs.org or @informs.

ELSE PRESS RELEASES FROM THIS DATE:

Memory-loss man case 'like nothing we have ever seen before'

2015-07-14

University of Leicester psychologist describes unique case as new to science 38-year-old fit and healthy man suffered memory loss after local anaesthetic and root-canal treatment at dentist For the past decade he can only remember up to 90 minutes And he awakes each day thinking it is the same day he went to the dentist Symptoms are akin to those depicted in movies such as Groundhog Day and Memento There is no evidence that the treatment at the dentist can be blamed for his condition "One of our reasons for writing up this individual's case was that we ...

How the lung repairs its wounds

2015-07-14

According to the World Health Organization (WHO), lung diseases are the third most common cause of death worldwide: toxic particles, infections, and chronic inflammatory responses pose a permanent threat to our lungs. To date, the regenerative mechanisms leading to healing of lung injury remain incompletely understood. Since few to no causal therapies are in place for most lung diseases, it is important to understand how these healing processes, which involve initial inflammation, fibrosis, and then resolution thereof, occur in the lung. Using novel mass spectrometry ...

NUS study shows potential of blue LEDs as novel chemical-free food preservation technology

2015-07-14

A team of scientists from the National University of Singapore (NUS) has found that blue light emitting diodes (LEDs) have strong antibacterial effect on major foodborne pathogens, and are most effective when in cold temperatures (between 4°C and 15°C) and mildly acidic conditions of around pH 4.5. This opens up novel possibilities of using blue LEDs as a chemical-free food preservation method. Acidic foods such as fresh-cut fruits and ready-to-eat meat can be preserved under blue LEDs in combination with chilling temperatures without requiring further chemical ...

Anti-stress hormone may provide indication of breast cancer risk

2015-07-14

A new study from Lund University in Sweden shows that women with low levels of an anti-stress hormone have an increased risk of getting breast cancer. The study is the first of its kind on humans and confirms previous similar observations from animal experiments. The recent findings on a potential new marker for the risk of developing breast cancer are presented in the renowned Journal of Clinical Oncology. The study focused on a hormone which circulates freely in the blood, enkephalin, with pain- and anxiety-reducing properties. Enkephalin also reinforces the immune ...

New classification system for brain tumours

2015-07-14

Despite modern chemoradiation therapy it is still very difficult to give reliable prognoses for malignant gliomas. Surgical removal of the glioma is still the preferred method of treatment. Doctors at Universitätsklinikum Erlangen's Department of Neurosurgery have now developed a new procedure for analysing radiological imaging scans which makes it possible to predict the course of a disease relatively precisely. Their findings have now been published in the journal 'Scientific Reports'.* The Friedlein Grading A/B (FGA/B) classification system - named after the physician ...

MRI studies point to brain connectivity changes in autism spectrum disorders

2015-07-14

July 14, 2015 - Studies using magnetic resonance imaging (MRI) techniques are beginning to reveal differences in brain connectivity--the ways that different parts of the brain are connected to each other and work together--in people with autism spectrum disorders (ASD), reports a review in the Harvard Review of Psychiatry. The journal is published by Wolters Kluwer. Some common themes are beginning to emerge from research on structural and functional brain connectivity in ASD, according to David Kennedy, PhD, and colleagues of University of Massachusetts Medical School. ...

Antidepressant trials exclude most 'real world' patients with depression

2015-07-14

July 14, 2015 - More than 80 percent of people with depression in the general population aren't eligible for clinical trials of antidepressant drugs, according to a study in the Journal of Psychiatric Practice. The journal is published by Wolters Kluwer. At least five patients would need to be screened to enroll just one patient meeting the typical inclusion and exclusion criteria for antidepressant registration trials (ARTs), suggests the new research by Drs. Sheldon Preskorn and Matthew Macaluso of University of Kansas School of Medicine-Wichita and Dr. Madhukar Trivedi ...

Benzodiazepines not recommended for patients with PTSD or recent trauma

2015-07-14

July 14, 2015 - Benzodiazepine drugs are widely used in patients with posttraumatic stress disorder (PTSD), but available evidence suggests that they are not effective--and may even be harmful, concludes a systematic review and meta-analysis in the July Journal of Psychiatric Practice. The journal is published by Wolters Kluwer. "Benzodiazepines are ineffective for PTSD treatment and prevention, and risks associated with their use tend to outweigh potential short-term benefits," write Dr. Jeffrey Guina and colleagues from Wright State University, Dayton, Ohio. They also ...

Revealed: Positronium's behavior in particle billiards

2015-07-14

Collision physics can be like a game of billiards. Yet in the microscopic world, the outcome of the game is hard to predict. Fire a particle at a group of other particles, and they may scatter, combine or break apart, according to probability distributions governed by quantum mechanics. These processes can tell us about fundamental properties of matter and, if antimatter projectiles are used, also about matter-antimatter interactions. Scientists at UCL have finally answered one of the basic questions that has remained outstanding until now: if, in a collision with matter, ...

Algae, quinoa, legumes top list of alternative protein choices

2015-07-14

CHICAGO-- Algae is evolving as the next new alternative protein source consumers are anxious to bite into as an ingredient in crackers, snack bars, cereals and breads, according to a July 12th presentation at IFT15: Where Science Feeds Innovation hosted by the Institute of Food Technologists (IFT) in Chicago. Algae, quinoa and pulses are considered by some food technologists to be the best protein sources and strong alternatives to slow meat consumption, reduce food waste and help feed the world's growing population. Algae is a new vegan source of protein with a comparable ...